Results 1 to 10 of about 319,869 (211)

Adjuvant Therapy: Melanoma [PDF]

Journal of Skin Cancer, 2011
With an incidence that is increasing at 2–5% per year, cutaneous melanoma is an international scourge that disproportionately targets young individuals. Despite much research, the treatment of advanced disease is still quite challenging. Immunotherapy with high-dose interferon-α2b or interleukin-2 benefits a select group of patients in the adjuvant and
Diwakar Davar, Ahmad Tarhini, John M. Kirkwood   +2 more
openaire   +3 more sources

Adjuvant Therapy Trials [PDF]

The Cancer Journal, 2016
In 2015, ramucirumab and TAS-102 became the 10th and 11th drugs approved by the Food and Drug administration for the treatment of patients with colorectal cancer, not counting leucovorin, and yet only 3 agents, 5-fluorouracil, capecitabine, and oxaliplatin, have proven benefit in adjuvant treatment.
Carling, Ursem, Katherine, Van Loon, Alan, Venook   +2 more
openaire   +2 more sources

Adjuvant Dermatological Therapy

JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY, 2021
não ...
Sociedade Brasileira de TMO SBTMO, Marcia de Matos Silva, Patricia Karla de Souza   +2 more
openaire   +2 more sources

Postoperative adjuvant therapy [PDF]

Journal of Hepato-Biliary-Pancreatic Sciences, 2011
AbstractAfter a lengthy search for an effective treatment for resected pancreatic cancer, evidence accumulated in the past 10 years shows that adjuvant chemotherapy is firmly established as offering a modest but real improvement in overall survival.
Tomoo, Kosuge, Yoshihiro, Sakamoto, Hideki, Ueno   +2 more
openaire   +2 more sources

Adjuvant Therapy for Melanoma [PDF]

The Cancer Journal, 2012
Estimates from the U.S. Surveillance, Epidemiology, and End Results registry suggest that melanoma incidence will reach 70,230 cases in 2011, of whom 8790 will die. The rising incidence and predilection for young individuals makes this tumor a leading source of lost productive years in the society.High-dose interferon-α-2b is the only agent approved ...
Diwakar, Davar, Ahmad A, Tarhini, John M, Kirkwood   +2 more
openaire   +2 more sources

Adjuvant Therapy [PDF]

JAMA Oncology, 2015
Howard Jack, West, Jill O, Jin
openaire   +2 more sources

Adjuvant Therapy [PDF]

Jornal Brasileiro de Nefrologia, 2014
Carlos Eduardo, Poli de Figueiredo, Elvino, Barros   +1 more
openaire   +2 more sources

Adjuvant Therapy [PDF]

Suizo, 2020
Katsuhiko UESAKA, Hidetoshi EGUCHI, Atsushi KANNO, Satoaki NAKAMURA, Toshio NAKAGOHRI   +4 more
openaire   +3 more sources

Treatment differences in IDH-wildtype glioma - the impact of surgery and adjuvant therapy. [PDF]

J Neurooncol
Keric N, Krenzlin H, Lange F, Dauth A, Freyschlag CF, Schnellg O, Misch M, von der Brelie C, Gempt J, Krigers A, Wagner A, Mielke D, Sommer C, Brockmann MA, Meyer B, Rohde V, Vajkoczy P, Beck J, Thomé C, Ringel F.   +19 more
europepmc   +1 more source

The evolving role of ctDNA in colorectal cancer: guidance of adjuvant therapy or surveillance strategies? [PDF]

Transl Gastroenterol Hepatol
Barrett LG, Gangi A, Hendifar A, Osipov A, Atkins K, Zaghiyan K, Nasseri Y, Murrell Z, Waters K, Mehta P, Zell JA, Hitchins MP, Gong J.   +12 more
europepmc   +1 more source